Morgan Chevalier, Firas Fadel, Tímea Májer, Dániel Péter Magda, Lili Gerendás, Ferenc Kilin, Zoltán Zsolt Nagy, Arnold Szabó, Botond Roska, Guilherme Testa-Silva
{"title":"利用超灵敏人体TRPV1通道对盲人视网膜进行工程红外光检测。","authors":"Morgan Chevalier, Firas Fadel, Tímea Májer, Dániel Péter Magda, Lili Gerendás, Ferenc Kilin, Zoltán Zsolt Nagy, Arnold Szabó, Botond Roska, Guilherme Testa-Silva","doi":"10.1016/j.tibtech.2025.07.033","DOIUrl":null,"url":null,"abstract":"<p><p>Engineering infrared light sensitivity in the blind human retina could restore visual function in patients with regional retinal degeneration. However, current approaches are complex and contain non-human biological components. Using rational protein design, we engineered human transient receptor potential vanilloid 1 (hTRPV1) channels (Δ786-840) with temperature sensitivity that shifted from 45 to 41°C, which enabled near-infrared (NIR) light-induced heat activation of mammalian cells at close to physiological temperatures. When expressed in ganglion cells of human retinal explants, Δ786-840 TRPV1 generated robust spiking responses to brief NIR light-induced temperature transients. In addition, increasing intensity of radiation evoked graded responses correlating with increasing firing frequencies. Unlike previous approaches, which used non-human TRPV1 channels, risking immune reactions, and a multicomponent system that poses barriers to clinical implementation, this single-component human-derived approach eliminates immunogenicity concerns, addressing a major challenge to clinical translation, and allows gene delivery using adeno-associated virus (AAV) vectors.</p>","PeriodicalId":23324,"journal":{"name":"Trends in biotechnology","volume":" ","pages":""},"PeriodicalIF":14.9000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Engineering infrared light detection in blind human retina using ultrasensitive human TRPV1 channels.\",\"authors\":\"Morgan Chevalier, Firas Fadel, Tímea Májer, Dániel Péter Magda, Lili Gerendás, Ferenc Kilin, Zoltán Zsolt Nagy, Arnold Szabó, Botond Roska, Guilherme Testa-Silva\",\"doi\":\"10.1016/j.tibtech.2025.07.033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Engineering infrared light sensitivity in the blind human retina could restore visual function in patients with regional retinal degeneration. However, current approaches are complex and contain non-human biological components. Using rational protein design, we engineered human transient receptor potential vanilloid 1 (hTRPV1) channels (Δ786-840) with temperature sensitivity that shifted from 45 to 41°C, which enabled near-infrared (NIR) light-induced heat activation of mammalian cells at close to physiological temperatures. When expressed in ganglion cells of human retinal explants, Δ786-840 TRPV1 generated robust spiking responses to brief NIR light-induced temperature transients. In addition, increasing intensity of radiation evoked graded responses correlating with increasing firing frequencies. Unlike previous approaches, which used non-human TRPV1 channels, risking immune reactions, and a multicomponent system that poses barriers to clinical implementation, this single-component human-derived approach eliminates immunogenicity concerns, addressing a major challenge to clinical translation, and allows gene delivery using adeno-associated virus (AAV) vectors.</p>\",\"PeriodicalId\":23324,\"journal\":{\"name\":\"Trends in biotechnology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":14.9000,\"publicationDate\":\"2025-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1016/j.tibtech.2025.07.033\",\"RegionNum\":1,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1016/j.tibtech.2025.07.033","RegionNum":1,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Engineering infrared light detection in blind human retina using ultrasensitive human TRPV1 channels.
Engineering infrared light sensitivity in the blind human retina could restore visual function in patients with regional retinal degeneration. However, current approaches are complex and contain non-human biological components. Using rational protein design, we engineered human transient receptor potential vanilloid 1 (hTRPV1) channels (Δ786-840) with temperature sensitivity that shifted from 45 to 41°C, which enabled near-infrared (NIR) light-induced heat activation of mammalian cells at close to physiological temperatures. When expressed in ganglion cells of human retinal explants, Δ786-840 TRPV1 generated robust spiking responses to brief NIR light-induced temperature transients. In addition, increasing intensity of radiation evoked graded responses correlating with increasing firing frequencies. Unlike previous approaches, which used non-human TRPV1 channels, risking immune reactions, and a multicomponent system that poses barriers to clinical implementation, this single-component human-derived approach eliminates immunogenicity concerns, addressing a major challenge to clinical translation, and allows gene delivery using adeno-associated virus (AAV) vectors.
期刊介绍:
Trends in Biotechnology publishes reviews and perspectives on the applied biological sciences, focusing on useful science applied to, derived from, or inspired by living systems.
The major themes that TIBTECH is interested in include:
Bioprocessing (biochemical engineering, applied enzymology, industrial biotechnology, biofuels, metabolic engineering)
Omics (genome editing, single-cell technologies, bioinformatics, synthetic biology)
Materials and devices (bionanotechnology, biomaterials, diagnostics/imaging/detection, soft robotics, biosensors/bioelectronics)
Therapeutics (biofabrication, stem cells, tissue engineering and regenerative medicine, antibodies and other protein drugs, drug delivery)
Agroenvironment (environmental engineering, bioremediation, genetically modified crops, sustainable development).